CFG - About us

Bernhard started working with CRISPR technology in 2013, shortly after publication of the seminal papers describing CRISPR/Cas9 application in eukaryotic cells. Since then, his work has focused on both CRISPR precision genome engineering and the applications of CRISPR in genetic screening. In 2017, he became Scientific Director and Head of CFG.

Soniya joined CFG in 2019. Previously, she worked as a Lab Manager and Post Doctoral Fellow in the field of DNA repair and cancer, thus bringing in organizational skills and experience as a molecular biologist.

Miriam joined the CFG facility in 2020. She has previous experience as a lab technician in a biochemical lab where she used CRISPR in a myogenic study of the DMD gene.

Anneke joined CFG in 2020. She previously used genome engineering techniques in her postdoctoral research to study transcriptional regulation in cancer. Anneke mainly focuses on precision editing, designing and using different CRISPR modalities such as HDR, base-editing and prime editing to create edited cell lines.

Olga joined CFG in 2021. With a Master’s degree in Chemistry, a PhD from Karolinska Institutet in S. pombe transcriptional regulation, and postdoctoral research in drug discovery, Olga brings a wide range of technologies and expertise to CFG.

Stefina joined in May 2022. With her previous experience as a customer service representative and a PhD from Karolinska Institutet in DNA topology and genome stability, Stefina brings a customer-oriented mindset and strong expertise in molecular biology. 

Alexander joined the CFG facility as a research assistant in October 2023, after having worked there as an Erasmus master’s student intern. He focuses on the development of a pooled CRISPR genetic screen platform compatible with in situ sequencing methods for in situ guide RNA readout.